TORONTO DOMINION BANK - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$488
+48700.0%
65
-11.0%
0.00%
Q2 2023$1
-99.5%
73
-99.7%
0.00%
Q1 2023$20425,400
+41539.3%
0.00%
Q2 2022$061
-14.1%
0.00%
Q1 2022$071
+31.5%
0.00%
Q4 2021$054
+134.8%
0.00%
Q3 2021$023
-58.2%
0.00%
Q2 2021$055
+266.7%
0.00%
Q1 2021$015
-80.8%
0.00%
Q3 2020$078
+239.1%
0.00%
Q1 2020$0
-100.0%
23
-93.3%
0.00%
Q4 2019$2,000342
+159.1%
0.00%
Q3 2019$0132
-10.8%
0.00%
Q2 2019$0148
+410.3%
0.00%
Q1 2019$029
+141.7%
0.00%
Q4 2018$0
-100.0%
12
-84.4%
0.00%
Q3 2018$1,00077
+234.8%
0.00%
Q2 2018$0
-100.0%
23
-59.6%
0.00%
Q4 2017$1,00057
+850.0%
0.00%
Q3 2017$060.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders